XL-protein and DNX Biopharmaceuticals Announce Collaboration to Develop Novel Inflammasome-Directed Therapeutics using PASylation® Technology
Freising, Germany and San Diego, CA, February 25, 2020 -- XL-protein…
DNX Biopharmaceuticals Announces Collaboration With Lung Cancer Initiative at Johnson & Johnson
San Diego, California--(Newsfile Corp. - February 18, 2020) -…
Akari Therapeutics Announces Preclinical Ophthalmic Data Showing Nomacopan Reduces Both Vascular Endothelial Growth Factor (VEGF) and Retinal Inflammation Supporting Nomacopan as a Potential Treatment Option for Back-of-the-Eye Diseases
NEW YORK and LONDON, Jan. 27, 2020 (GLOBE NEWSWIRE) -- Akari…